Short Interest Update on OraSure Technologies (OSUR)

OraSure Technologies (OSUR) : Traders are negative on OraSure Technologies (OSUR), as it has 3.3% of short positions outstanding compared to its float. The total shorts have reduced by -433,773 shares, which is a -19.9% reduction. From Jul 29, 2016, to August 15, 2016, the shorts came down from,2,182,027 to 1,748,254 shares. While the daily trading volume of the stock is 639,672, there are 3 days remaining to cover the open short positions. The short interest indicates that the traders dont see a large downside in the stock from the current levels. The short interest information was released on Wednesday Aug 24th after the market close.

OraSure Technologies (NASDAQ:OSUR): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $7.48 and $7.42 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $8.20. The buying momentum continued till the end and the stock did not give up its gains. It closed at $7.74, notching a gain of 10.57% for the day. The total traded volume was 6,281,153 . The stock had closed at $7.00 on the previous day.


OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test, OraQuick ADVANCE, OraSure HIV-1 oral specimen collection device, OraQuick HCV rapid antibody test, Intercept oral fluid drug testing system, OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. Saliva Alcohol test. The Company also manufactures and sells a range of cryosurgical products. Through its wholly owned subsidiary, DNA Genotek Inc., the Company provides oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.